As the demands of clinical development change, being nimble and adaptable becomes more critical. Meeting the evolving needs of multiple stakeholders ultimately determine the probability of success. And new agile development models are required to meet customer needs and increasing competitive intensity. Innovative technologies allow pharma companies to explore and pursue patient-centric approaches to trial execution and data collection in ways that were previously cost-prohibitive.

The Clinical Development Transformation Solution focuses on designing new clinical development operating models that drive the efficient and timely generation of compliant proof points to meet the needs of a diverse set of stakeholders. Three key principles drive this innovative solution: implementing current best practices, breaking the commonplace paradigm of clinical development, and exploring novel approaches using technology and direct-to-patient interaction.